The BRAAVE2020 study investigated the efficacy of switching Black Americans living with HIV to a B/F/TAF single-pill regimen.

Secured multi-regional patent assets, strengthening Ainos' AI Nose technology. Expanded VELDONA® patent portfolio with a new invention patent for treatments and preventions for coronavirus infections.

Foster City, Calif.-based Gilead (GILD) had net income of $1.25 billion, or $1.00 a share, for the quarter, down from $2.18 billion, or $1.73 a share, in the year-earlier period. Adjusted for one-time ...

A new study found that iron supplements are safe for children with HIV in Uganda, as they improve hemoglobin levels without ...

How trustworthy is a positive HIV test result? How probable is an actual infection when the test is positive? Even ...

Donald Trump defeated Kamala Harris early Wednesday morning in a presidential election defined by the Republican candidates’ ...

Researchers in South Africa are currently testing a longer-acting version of the dapivirine vaginal ring, a device designed ...

A new World Health Organisation study published on Tuesday in eBioMedicine has named 17 pathogens that regularly cause ...

Opens in a new tab or window Real-world data presented at the 2024 IDWeek annual meeting in Los Angeles highlighted the ...

A recent study reveals that nearly 20% of United States physicians treating HIV patients plan to leave or reduce their ...

Studies have shown that people living with HIV are more vulnerable to severe cases of mpox. However, even with heightened risk, they face difficulties accessing the vaccine. Many HIV-positive ...

José Benitez, the new Philadelphia FIGHT CEO, aims to expand the organization's services and increase community access.